CompletedPhase 2NCT04579510

Immunogenicity nOPV2 With and Without bOPV

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
Amanda Wilkinson, PhD
Centers for Disease Control and Prevention
Intervention
Novel monovalent oral poliovirus vaccine type 2 (nOPV2)(biological)
Enrollment
795 target
Eligibility
All sexes
Timeline
20212021

Study locations (1)

Collaborators

International Centre for Diarrhoeal Disease Research, Bangladesh

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04579510 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials